Xianbin Ma
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
Papers in
- Biomaterials 18
- Nanoparticle-Based Drug Delivery 18
-
- Nanoplatforms for cancer theranostics 31
Xianbin Ma
41 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Biomaterials 627
- Biomedical Engineering 1.2k
- Immunology 368
- Molecular Medicine 80
- Pharmaceutical Science 70
Countries citing papers authored by Xianbin Ma
This map shows the geographic impact of Xianbin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbin Ma more than expected).
Fields of papers citing papers by Xianbin Ma
This network shows the impact of papers produced by Xianbin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbin Ma. The network helps show where Xianbin Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianbin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 144 | |
| 10 | 2021 | 125 | |
| 11 | 2021 | 61 | |
| 12 | 2021 | 31 | |
| 13 | 2021 | 101 | |
| 14 | 2021 | 18 | |
| 15 | Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy Hit paper breakdown → | 2021 | 266 |
| 16 | 2021 | 66 | |
| 17 | 2021 | 58 | |
| 18 | 2020 | 42 | |
| 19 | 2020 | 13 | |
| 20 | 2019 | 43 |
About Xianbin Ma
Xianbin Ma is a scholar working on Biomaterials, Biomedical Engineering, Immunology, Oncology and Molecular Biology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (18 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (7 papers), Immune cells in cancer (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Inflammasome and immune disorders (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (627 citations), Biomedical Engineering (1.2k citations), Immunology (368 citations), Molecular Medicine (80 citations) and Pharmaceutical Science (70 citations). Xianbin Ma has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Zhigang Xu, Zhi‐Jun Sun, Peng Xue, Yuejun Kang, Tian Zhang, Mengyun Liang, Die Jia, Shao‐Chen Yang, Qi‐Chao Yang and Yuan Gao. Their work appears in journals such as Chinese Chemical Letters, ACS Applied Materials & Interfaces, Acta Pharmaceutica Sinica B, Advanced Healthcare Materials and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.